Free Trial

BioXcel Therapeutics (BTAI) Insider Trading & Ownership

BioXcel Therapeutics logo
$1.24 -0.06 (-4.62%)
Closing price 05/7/2026 04:00 PM Eastern
Extended Trading
$1.25 +0.01 (+1.13%)
As of 05:02 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

BioXcel Therapeutics (NASDAQ:BTAI) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
3.70%
Number Of
Insiders Buying
(Last 3 Years)
0
Number Of
Insiders Selling
(Last 3 Years)
6
Amount Of
Insider Selling
(Last 3 Years)
$1.23M
Get BTAI Insider Trade Alerts

Want to know when executives and insiders are buying or selling BioXcel Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

BTAI Insider Buying and Selling by Quarter

BioXcel Therapeutics Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/16/2024
Richard I Steinhart
CFO
Sell36$5.76$207.36  
12/16/2024Sell194$5.76$1,117.44  
12/16/2024
Vincent O'neill
Insider
Sell10$5.60$56.00  
10/3/2024
Matthew T Wiley
Insider
Sell392$8.80$3,449.60  
10/3/2024
Richard I Steinhart
CFO
Sell448$8.80$3,942.40  
9/16/2024
Frank Yocca
Insider
Sell22$11.04$242.88  
9/16/2024
Richard I Steinhart
CFO
Sell22$11.04$242.88  
9/16/2024Sell123$11.04$1,357.92  
6/17/2024
Frank Yocca
Insider
Sell23$20.48$471.04  
6/17/2024Sell133$20.48$2,723.84  
6/4/2024Sell7,875$26.08$205,380.00  
4/4/2024
Richard I Steinhart
CFO
Sell66$42.08$2,777.28  
4/4/2024Sell329$41.92$13,791.68  
4/4/2024
Vincent O'neill
Insider
Sell10$41.92$419.20  
6/15/2023Sell1,875$344.64$646,200.00  
5/22/2023Sell406$412.64$167,531.84  
5/15/2023
Javier Rodriguez
Insider
Sell111$437.12$48,520.32  
5/15/2023
Richard I Steinhart
CFO
Sell312$434.72$135,632.64  
(Data available from 1/1/2013 forward)

BTAI Insider Trading Activity - Frequently Asked Questions

The list of insiders at BioXcel Therapeutics includes Frank Yocca, Javier Rodriguez, Matthew T Wiley, Richard I Steinhart, Vimal Mehta, and Vincent O'neill. Learn more on insiders at BTAI.

3.70% of BioXcel Therapeutics stock is owned by insiders. Learn more on BTAI's insider holdings.

The following insiders have sold BTAI shares in the last 24 months: Frank Yocca ($713.92), Matthew T Wiley ($3,449.60), Richard I Steinhart ($4,392.64), Vimal Mehta ($210,579.20), and Vincent O'neill ($56.00).

Insiders have sold a total of 9,278 BioXcel Therapeutics shares in the last 24 months for a total of $219,191.36 sold.

BioXcel Therapeutics Active Insiders



This page (NASDAQ:BTAI) was last updated on 5/8/2026 by MarketBeat.com Staff.
From Our Partners